These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5083180)

  • 1. [Antamanide. XV. Derivatives at the phenolic side of tyrosine 6- and tyrosine 5- antamanide].
    Wieland T; Rietzel C; Seeliger A
    Justus Liebigs Ann Chem; 1972 May; 759():63-70. PubMed ID: 5083180
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antamanide. XVI. All-D-retro-antamanide and D-tyr 6 -all-D-retro-antamanide].
    Wieland T; Penke B; Birr C
    Justus Liebigs Ann Chem; 1972 May; 759():71-5. PubMed ID: 5083181
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antamanide, VI. Synthesis of some structural variants of antamanide with exchanged amino acids in position 1 and 4].
    Wieland T; Lapatsanis L; Faesel J; Konz W
    Justus Liebigs Ann Chem; 1971 May; 747():194-206. PubMed ID: 5088055
    [No Abstract]   [Full Text] [Related]  

  • 4. The conformation of the sodium complex of a biologically active analog of antamanide in the crystalline state.
    Karle IL
    Biochemistry; 1974 May; 13(10):2155-62. PubMed ID: 4826889
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antamanide. X. The tyrosine 6 -analogue of antamanide].
    Wieland T; Rietzel C
    Justus Liebigs Ann Chem; 1971 Dec; 754():107-12. PubMed ID: 5170516
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antamanide. XI. Merrifield synthesis of tyrosine-containing analogues of antamanide].
    Wieland T; Birr C; Frodl R; Lochinger W; Stahnke G
    Justus Liebigs Ann Chem; 1972 Mar; 757():136-46. PubMed ID: 4672883
    [No Abstract]   [Full Text] [Related]  

  • 7. [Peptide syntheses. XLIX. Automated synthesis of structural variants of antamanide with L-alpha-aminobutyric acid in 1- and 4-positions].
    Wieland T; Birr C; von Dungen A
    Justus Liebigs Ann Chem; 1971 May; 747():207-12. PubMed ID: 5088056
    [No Abstract]   [Full Text] [Related]  

  • 8. Approximate treatment of the conformational characteristics of the cyclic deca-L-peptide antamanide and its sodium complex in solution.
    Tonelli AE
    Biochemistry; 1973 Feb; 12(4):689-92. PubMed ID: 4691513
    [No Abstract]   [Full Text] [Related]  

  • 9. Conformational stability of antamanide and analogs. Crystal structure of perhydrosymmetric antamanide, cyclic (-Val-Pro-Pro-Cha-Cha-Val-Pro-Pro-Cha-Cha-).
    Karle IL; Flippen-Anderson JL; Wieland T
    Int J Pept Protein Res; 1989 Jun; 33(6):422-7. PubMed ID: 2777476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery, isolation, elucidation of structure, and synthesis of antamanide.
    Wieland T
    Angew Chem Int Ed Engl; 1968 Mar; 7(3):204-8. PubMed ID: 4966639
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparative merits of the mixed anhydride (MA) method in the excess use of DDZ-amino acids in the peptide synthesis of biologically active new antamanide analogues.
    Birr C; Nassal M; Pipkorn R
    Int J Pept Protein Res; 1979 Mar; 13(3):287-95. PubMed ID: 581869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium perhydroantamanide complex (2:1): exposure of the peptide backbone in the analog of antamanide with antitoxic impotency.
    Karle IL
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7155-9. PubMed ID: 3864151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phalloidin antagonists/3rd communication: effects of antamanide derivatives in isolated perfused rat livers (author's transl)].
    Frimmer M; Petzinger E
    Arzneimittelforschung; 1975 Sep; 25(9):1423-6. PubMed ID: 1242667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antamanide conformations in nonaqueous media. Dependence on hydrogen-bond acceptor properties of solvent.
    Patel DJ
    Biochemistry; 1973 Feb; 12(4):667-76. PubMed ID: 4691511
    [No Abstract]   [Full Text] [Related]  

  • 15. Fourth polymorph of [Phe4 Val6] antamanide (pentahydrate).
    Karle I; Wieland T
    Int J Pept Protein Res; 1987 May; 29(5):596-603. PubMed ID: 3610474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic peptides. XII. Synthesis of AM-toxin III and its analogs.
    Kanmera T; Izumiya N
    Int J Pept Protein Res; 1982 Jan; 19(1):79-87. PubMed ID: 7118384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive activity of antamanide and some of its analogues.
    Siemion IZ; Pedyczak A; Trojnar J; Zimecki M; Wieczorek Z
    Peptides; 1992; 13(6):1233-7. PubMed ID: 1494502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformation of antamanide-sodium in solution.
    Patel DJ
    Biochemistry; 1973 Feb; 12(4):677-88. PubMed ID: 4691512
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on antamanide. XIV. Mode of action].
    Wieland T; Faulstich H; Jahn W; Govindan MV; Puchinger H; Kopitar Z; Schmaus H; Schmitz A
    Hoppe Seylers Z Physiol Chem; 1972 Aug; 353(8):1337-45. PubMed ID: 5082086
    [No Abstract]   [Full Text] [Related]  

  • 20. Conformation of the lithium ion complex of antamanide, a cyclic decapeptide and ion carrier, in the crystalline state.
    Karle IL
    J Am Chem Soc; 1974 Jun; 96(12):4000-6. PubMed ID: 4851143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.